Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
NCT05498090
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Klinefelter Syndrome
Interventions
DRUG:
Fenofibrate 145 mg
Sponsor
University of Colorado, Denver
Collaborators
[object Object]